From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Statins to Prevent Perioperative Cardiovascular Events

In high-risk patients, several weeks of statin therapy before vascular surgery led to less ischemia and fewer MIs.

Rupture of coronary plaque probably accounts for half of perioperative myocardial infarctions. Because statins have plaque-stabilizing effects, they are plausible candidates for preventing perioperative MIs.

In the industry-supported DECREASE-III trial, Dutch researchers randomized 497 statin-naive patients scheduled for elective vascular surgery (carotid, aortic, or lower extremity) to receive daily extended-release fluvastatin (80 mg) or placebo. Fluvastatin was started at least several weeks before surgery and was continued for 1 month postoperatively. Patients were at high risk: 28% had suffered previous MIs, 38% had experienced previous cerebrovascular events, 57% were hypertensive, and 20% had diabetes.

The primary endpoint, myocardial ischemia (defined as transient electrocardiographic changes or release of troponin T) within 30 days after surgery, occurred significantly less often in the fluvastatin group than in the placebo group (11% vs. 19%, P=0.01). A secondary endpoint (nonfatal MI or cardiovascular-related death) also occurred less often with fluvastatin (5% vs. 10%, P=0.03). No rhabdomyolysis or other side effects were reported.

Comment: In this study, statins were associated with better outcomes, without any apparent adverse effects. However, the primary endpoint (ischemia) is softer and less clinically relevant than the secondary endpoint. Moreover, most of these high-risk patients probably should have been taking statins long-term, regardless of their need for vascular surgery. Because of these caveats, and because fluvastatin was not associated with significantly better perioperative outcomes in a recent study of lower-risk patients (JW Gen Med Jun 18 2009), the benefits of initiating statins preoperatively should be validated in additional studies.

Allan S. Brett, MD

Published in Journal Watch General Medicine September 3, 2009

Citation(s):

Schouten O et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med 2009 Sep 3; 361:980.

Reader Remarks:

Read all Reader Remarks on this article

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

(more...)

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.